Frequency Therapeutics Stock Fundamentals
| FREQDelisted Stock | USD 0.52 0.03 5.45% |
Frequency Therapeutics fundamentals help investors to digest information that contributes to Frequency Therapeutics' financial success or failures. It also enables traders to predict the movement of Frequency Stock. The fundamental analysis module provides a way to measure Frequency Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Frequency Therapeutics stock.
Frequency |
Frequency Therapeutics Company Current Valuation Analysis
Frequency Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Frequency Therapeutics Current Valuation | 512.86 M |
Most of Frequency Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Frequency Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Frequency Therapeutics has a Current Valuation of 512.86 M. This is 96.43% lower than that of the Biotechnology sector and 88.96% lower than that of the Health Care industry. The current valuation for all United States stocks is 96.91% higher than that of the company.
Frequency Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Frequency Therapeutics's current stock value. Our valuation model uses many indicators to compare Frequency Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Frequency Therapeutics competition to find correlations between indicators driving Frequency Therapeutics's intrinsic value. More Info.Frequency Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Frequency Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Frequency Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Frequency Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Frequency Therapeutics could also be used in its relative valuation, which is a method of valuing Frequency Therapeutics by comparing valuation metrics of similar companies.Frequency Therapeutics is currently under evaluation in current valuation category among its peers.
Frequency Fundamentals
| Return On Equity | -1.0 | |||
| Return On Asset | -0.42 | |||
| Current Valuation | 512.86 M | |||
| Shares Outstanding | 36.52 M | |||
| Shares Owned By Insiders | 7.26 % | |||
| Shares Owned By Institutions | 14.12 % | |||
| Number Of Shares Shorted | 365.89 K | |||
| Price To Earning | (7.43) X | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 7.50 X | |||
| Gross Profit | (42.02 M) | |||
| EBITDA | (80.62 M) | |||
| Net Income | (81.58 M) | |||
| Cash And Equivalents | 111.02 M | |||
| Cash Per Share | 3.15 X | |||
| Total Debt | 42.95 M | |||
| Debt To Equity | 0.47 % | |||
| Current Ratio | 6.77 X | |||
| Book Value Per Share | 0.99 X | |||
| Cash Flow From Operations | (58.24 M) | |||
| Short Ratio | 3.51 X | |||
| Earnings Per Share | (1.90) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 46 | |||
| Beta | 0.77 | |||
| Market Capitalization | 10.94 M | |||
| Total Asset | 121.24 M | |||
| Retained Earnings | (261.67 M) | |||
| Working Capital | 66.47 M | |||
| Current Asset | 238.83 M | |||
| Current Liabilities | 56.95 M | |||
| Z Score | -4.41 | |||
| Net Asset | 121.24 M |
About Frequency Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Frequency Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Frequency Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Frequency Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Pair Trading with Frequency Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Frequency Stock
| 0.76 | TCHH | Trustcash Holdings | PairCorr |
| 0.73 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.58 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.53 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.51 | HYMTF | Hyundai Motor | PairCorr |
The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.
The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |